Prostate cancer and curcumin - Add spice to your life

被引：69

作者：

Aggarwal, Bharat B. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA

来源：

CANCER BIOLOGY & THERAPY | 2008年 / 7卷 / 09期

关键词：

curcumin; EGFR; HER2; NFkB; prostate cancer; androgen dependent; androgen independent; PSA;

D O I：

10.4161/cbt.7.9.6659

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1438 / 1442

页数：5

共 56 条

[1] The convergence of cancer prevention and therapy in early-phase clinical drug development [J].

Abbruzzese, JL ;

Lippman, SM .

CANCER CELL, 2004, 6 (04) :321-326

[2] From chemoprevention to chemotherapy: common targets and common goals [J].

Aggarwal, BB ;

Takada, Y ;

Oommen, OV .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) :1327-1338

[3]

Aggarwal BB, 2003, ANTICANCER RES, V23, P363

[4] Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].

Aggarwal, S ;

Ichikawa, H ;

Takada, Y ;

Sandur, SK ;

Shishodia, S ;

Aggarwal, BB .

MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206

[5] Curcumin is an in vivo inhibitor of angiogenesis [J].

Arbiser, JL ;

Klauber, N ;

Rohan, R ;

van Leeuwen, R ;

Huang, MT ;

Fisher, C ;

Flynn, E ;

Byers, HR .

MOLECULAR MEDICINE, 1998, 4 (06) :376-383

[6] Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis [J].

Bharti, AC ;

Shishodia, S ;

Reuben, JM ;

Weber, D ;

Alexanian, R ;

Raj-Vadhan, S ;

Estrov, Z ;

Talpaz, M ;

Aggarwal, BB .

BLOOD, 2004, 103 (08) :3175-3184

[7] Curcumin (diferuloylmethane) inhibits receptor activator of NF-kB ligand-induced NF-kB activation in osteoclast precursors and suppresses osteoclastogenesis [J].

Bharti, AC ;

Takada, Y ;

Aggarwal, BB .

JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :5940-5947

[8] Curcurnin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells [J].

Bharti, AC ;

Donato, N ;

Aggarwal, BB .

JOURNAL OF IMMUNOLOGY, 2003, 171 (07) :3863-3871

[9] Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer [J].

Catz, SD ;

Johnson, JL .

ONCOGENE, 2001, 20 (50) :7342-7351

[10] NF-κB activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer [J].

Chen, CD ;

Sawyers, CL .

MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2862-2870

← 1 2 3 4 5 6 →